Tiagabine Hydrochloride

盐酸噻加宾

Report date: 2025/03/18 15:57:42
NME

Base Information

Drug NameTiagabine Hydrochloride
Drug Alias Name替加平tiagabinatiagabinum塞加宾tiagabine +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA transporter 1 inhibitorsGABA uptake inhibitors
TargetsGABA transporter 1
Therapy Area/IndicationsAnxiety DisordersCocaine-Related DisordersSeizures +[5] 
Global Approved IndicationsSeizuresEpilepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryDenmark
Original Approved Date1996/01/01
Country/TerritoryCanadaUnited StatesDenmark +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesCephalonBeijing Jingwei Yankang Medicine Research Institute Co Ltd
Inactive CompaniesThe Brigham and Women's HospitalNational Institute On Drug Abuse
Active IndicationsSeizuresEpilepsy
Inactive IndicationsAnxiety DisordersCocaine-Related DisordersSleep Apnea, Obstructive

Other Information

ATC CodeN03AG06
Related LinksWikipediaDrugBankKEGG